The results of the univariate analysis demonstrated that SOX2 and N1 (adjusted hazard ratio [HR]: 2.012, 95% CI: 1.116-4.026, p < 0.05) were independent factors predicting OS in patients with PAAD (Figure 9F). The gene discussed is SOX2; the disease is pancreatic adenocarcinoma.